7
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9921 | Infliximab | TNF | |
Infliximab is a humanized antibody against tumor necrosis factor α TNF-α) that is used in the treatment of Crohn's disease and rheumatoid arthritis. | |||
T76209 | DSTYSLSSTLTLSK TFA | ||
DSTYSLSSTLTLSK TFA, a generic human peptide, facilitates the quantitative detection of Infliximab (Avakine), a chimeric monoclonal IgG1 antibody targeting TNF-α, as indicated in study [1]. | |||
T36091 | LEESGGGLVQPGGSMK acetate | ||
LEESGGGLVQPGGSMK acetate is a proteolysis peptide found in Infliximab, a chimeric monoclonal IgG1 antibody. It serves as a component of Infliximab and can be employed for the quantitative analysis of this antibody. Infli... | |||
T39191 | DSTYSLSSTLTLSK | ||
DSTYSLSSTLTLSK, a human peptide, facilitates the quantitative detection of Infliximab (Avakine), a chimeric monoclonal IgG1 antibody. Infliximab specifically targets and binds to TNF-α. | |||
T76201 | LEESGGGLVQPGGSMK TFA | ||
LEESGGGLVQPGGSMK TFA, a proteolysis peptide component of Infliximab, serves for the quantitative analysis of the latter. Infliximab is a chimeric monoclonal IgG1 antibody, binding specifically to TNF-α [1]. | |||
T39521 | LEESGGGLVQPGGSMK | ||
LEESGGGLVQPGGSMK, a proteolysis peptide, is a constituent of Infliximab, a chimeric monoclonal IgG1 antibody that selectively binds to TNF-α. It can be employed for quantitative assessment of Infliximab. | |||
T39191L | DSTYSLSSTLTLSK acetate | DSTYSLSSTLTLSK acetate (177792-42-6 Free base) | Others |
DSTYSLSSTLTLSK acetate is a human generic peptide that can be used for the quantitative detection of infliximab. |